Stifel

Medical device company Wright Medical Group NV (NASDAQ: WMGI) is likely to return to sustainable double-digit growth in the coming quarters, according to Stifel. The Analyst Analyst Mathew Blackman initiated coverage of Wright Medical with a Buy rating and $34 price target. The Thesis Wright...

The bullish case for Zoetis Inc (NYSE: ZTS) has come to an end after the stock outperformed the S&P 500 index by 108 percent since spinning out from Pfizer Inc. (NYSE: PFE), according to Stifel. The Analyst Stifel's Jonathan Block downgraded Zoetis from Buy to Hold with a $95...

NVIDIA Corporation (NASDAQ: NVDA) unveiled its GeForce RTX product line Monday. The graphic cards are based on new and advanced Turing architecture, which creates realistic lighting and shadows. The products are the “holy grail of computer graphics,” Loup Ventures...

Carbonite Inc (NASDAQ: CARB), a "little guy" data protection company, has shown over the past few years a shift in its business strategy which warrants a bullish stance on the stock, according to Stifel. The Analyst Stifel's Brad Reback initiated coverage of Carbonite with a Buy...

With the IPO quiet period expiring, the sell-side is starting coverage of cybersecurity software company Tenable Holdings Inc (NASDAQ: TENB). The Analysts Morgan Stanley analyst Melissa Franchi initiated coverage of Tenable Holdings with an Equal-weight rating and $31 price target. Stifel...

Applied Materials, Inc. (NASDAQ: AMAT) shares were tumbling Friday following a disappointing earnings report. Here's what several Wall Street analysts had to say. Foundry Woes Memory and foundry uncertainty have clouded the near-term outlook for Applied Materials, Stifel analyst Patrick Ho...

NetApp Inc. (NASDAQ: NTAP) reported a first-quarter earnings beat Wednesday, and second-quarter guidance fell relatively in-line with consensus estimates. Wall Street Weighs In Deutsche Bank analyst Sherri Scribner maintained a Sell rating on NetApp and raised the price...

Papa John’s International, Inc. (NASDAQ: PZZA) is executing new strategies to restore confidence among investors and customers after the departure of founder John Schnatter in a racism scandal, according to Stifel.  The Analyst Stifel analyst Chris O'Cull upgraded Papa John...

After a huge year in 2017, GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) stock has traded mostly sideways so far in 2018. But one analysts believes GW will soon return to its winning ways. The Analyst Stifel analyst Paul Matteis initiated coverage of GW Pharma with a Buy rating and $181 price target....

Latin American airliner Copa Holdings, S.A. (NYSE: CPA)'s stock lost 15 percent through Thursday after the company's second-quarter results and guidance, but Stifel said in a downgrade note that investors should expect even more downside. The Analyst Stifel's Joseph...

Williams Companies Inc (NYSE: WMB), a provider of large-scale infrastructure connecting natural gas and related products to end markets, is a pure play on domestic natural gas production with an attractive business model, according to Stifel. The Analyst Stifel's Selman Akyol initiated coverage...

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), which already has two strong drugs in the market in the form of Ingrezza and the recently approved elagolix, has a promising pipeline ahead, according to Stifel.  The Analyst Analyst Paul Matteis initiated coverage of Neurocrine with a Buy rating...

Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR) is set to release its second-quarter earnings report after the bell Tuesday, and Stifel reviewed the stock ahead of the print.  The Analysts Stifel analyst Paul Matteis initiated coverage of Alder BioPharmaceuticals with a Buy rating and $30 price...

For Mid-America Apartment Communities Inc (NYSE: MAA), a multifamily REIT with roughly 100,000 apartment units and a small development platform, the multiple concerns moving forward outweigh the positives, according to Stifel. The Analyst Stifel's John Guinee downgraded Mid-America Apartment...

Essex Property Trust Inc (NYSE: ESS) reported a strong second-quarter earnings beat Wednesday. Earnings per share came in at $1.52 versus the $1.13 analysts were expecting. The Analyst Stifel analyst John Guinee upgraded Exxes from Hold to Buy and raised his price target from $235 to $260. The...